Jeffrey S. Heier, MD
Jeffrey S. Heier, M.D., is the Co-President and Medical Director, Director of the Vitreoretinal Service,and Director of Retina Research at Ophthalmic Consultants of Boston (OCB). Dr. Heier is one of the leading retinal clinical researchers in the country for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina. Dr. Heier is on the Executive Board of the Retina Society, the Executive Board of the American Society of Retina Specialists, and is Past President of the New England Ophthalmological Society. He is a scientific advisor to over thirty biotechnical or pharmaceutical companies, lectures nationally and internationally on research and innovative approaches to the treatment of retinal diseases, and has authored numerous works in peer-reviewed journals. Dr. Heier received his medical degree from Boston University, then did a transitional internship and ophthalmology residency at Fitzsimons Army Medical Center. Between his internship and residency, he served as a physician in a Combat Support Hospital in the Persian Gulf War, where he was awarded a Bronze Star. Dr. Heier then completed a vitreoretinal fellowship at OCB/Tufts School of Medicine.
David S Boyer, MD
David S. Boyer, M.D. is a Board-certified ophthalmologist specializing in the treatment of diseases of the retina and vitreous. He is Senior Partner at Retina-Vitreous Associates Medical Group with offices in Los Angeles, Beverly Hills, North Hollywood, Torrance, Pasadena and Tarzana, California. Dr. Boyer is a Clinical Professor of Ophthalmology with the University of Southern California/Keck School of Medicine in Los Angeles, CA. He has an extensive research background and is currently an investigator for various clinical trials. He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema. A widely-published author and avid lecturer, Dr. Boyer lectures nationally and internationally on retinal research and the innovative approach to the treatment of retinal diseases.
Peter Kaiser, MD
Peter K. Kaiser, M.D. is the Chaney Family Endowed Chair for Ophthalmology Research and a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine. He graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School. He completed an internal medicine internship at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute at the Cleveland Clinic, Cleveland, Ohio. As a RO1 NIH-funded investigator, Dr. Kaiser leads a team involved in the evaluation of vascular biology in AMD and diabetic retinopathy. He is director of the Cole Center for ocular Research and Evaluation (CORE). In addition, Dr Kaiser is actively involved in clinical research as Study Chairman of 7 major, multi-center, international clinical trials, and principal investigator in over 60 trials evaluating new treatments for AMD, diabetic retinopathy, and other retinal disorders. He is the founder and director of the Digital Optical Coherence Tomography Reading Center (DOCTR). Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, and more than 400 peer-reviewed papers. He is Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of Retina, Retina Today, and Ocular Surgery News.
Nadia Waheed, MD MPH
Dr Nadia Waheed is Director of the Boston Image Reading Center and on faculty at the Tufts University School of Medicine in Boston. Dr Waheed received her medical degree summa cum laude from the Aga Khan University Medical School and a Masters in Public Health from the Harvard School of Public Health. She completed a residency in Ophthalmology and a Fellowship in Retina from the Harvard Medical School/Massachusetts Eye and Ear Infirmary Program in Ophthalmology. She then joined the Cleveland Clinic Cole Eye Institute as faculty. This was followed by a year of International Ophthalmology, following which she joined the Tufts Medical Center in Boston in 2012
Dr Waheed’s research interests include advanced ocular imaging and specifically as related to the development of endpoints for clinical trials, diabetic eye disease and age related macular degeneration, as well as clinical trial design and analysis. Her work at the reading center includes developing and validating functional and imaging endpoints for clinical trials. She has published extensively with over 80 peer reviewed publications, over 30 chapters, and is the co-editor of two books in retinal imaging and OCT. She is on the editorial board of numerous peer reviewed Ophthalmology journals